Chapter 11 of 25
- Pathology and imaging establish facts
- Tumour board compares options
- Patient priorities shape consent
- Named team coordinates care
What you will learn
Know whom to ask for different needs; understand multidisciplinary decisions; prepare for coordinated care.
The main clinical specialists
A gynaecologic oncologist specializes in cancers of the female reproductive tract, including diagnostic assessment, surgery and fertility-sparing decisions. A radiation oncologist plans external-beam radiotherapy and brachytherapy. A medical oncologist manages systemic medicines such as chemotherapy, immunotherapy and targeted treatment. Roles overlap in some healthcare systems, but the treatment plan should have a clear coordinating clinician.
A radiologist interprets scans and may perform image-guided biopsies. A pathologist establishes the tissue diagnosis and relevant biomarkers. Specialist review matters when a rare histology, uncertain margin or unexpected scan finding could change treatment. Ask whether all reports and images are available before the definitive plan is made.
Support is part of treatment
Oncology nurses explain practical care, monitor symptoms and help identify urgent problems. A dietitian addresses poor intake, weight loss, diarrhoea and nutritional needs. A physiotherapist can support activity and lymphoedema management; pelvic-health therapists may help with bladder, bowel and sexual difficulties. A psychologist, counsellor or social worker can help with distress, relationships, costs, transport and work.
A fertility specialist should be involved before treatment when future pregnancy or preservation of eggs or embryos matters. Menopause and sexual-health specialists can address vaginal symptoms, hormone questions and intimacy. Palliative-care teams treat pain and other burdens at any stage, including during treatment intended to cure; their involvement does not mean treatment has been abandoned.
What a tumour board does
A multidisciplinary tumour board considers pathology, imaging, stage, fitness, prior treatment and goals. It can help avoid unnecessary combinations of major surgery and pelvic radiation when one definitive approach is likely to suffice. For unusual disease, pregnancy, recurrence or major health problems, specialist discussion is especially valuable.
A board recommendation is not a substitute for your informed consent. Ask about benefits, harms, alternatives, fertility implications and the consequences of delay. If two reasonable options exist, explain which outcomes matter most to you. A second opinion can be useful, particularly before an irreversible operation or complex salvage treatment, while keeping urgent care moving.
Making appointments work
Bring a current medication list, allergies, scan files, pathology reports and previous treatment records. Write your three most important questions first. If you wish, take a trusted person to help listen and make notes. Ask permission before recording a consultation. Request written information in a language you understand.
Before leaving, know the next step, who will arrange it, the expected timing and whom to contact outside clinic hours. If different clinicians give apparently conflicting advice, ask them to reconcile the plan rather than choosing between fragments yourself. Tell the team about travel, caregiving, disability and affordability barriers early enough to arrange support.
Misconception and common question
“Palliative care is only for the final days of life” is false. Who is in charge when several doctors are involved? Ask for the named coordinator and a written shared plan; coordinated care should not require the patient to resolve clinical disagreements.
Take-home messages
Cancer control and quality of life belong in the same discussion. Involve fertility and supportive specialists early. Keep a clear contact route and a shared treatment summary.
References and review status
- Cibula et al. ESGO/ESTRO/ESP cervical cancer guidelines, 2023 update
- NCI — Cervical cancer treatment overview
- NCI — Support for people with cancer and families
Evidence/editorial check: 28 October 2026. AI-assisted preparation is separate from physician sign-off. Individual physician review is not recorded. Local approvals, resources and clinical guidance must be confirmed by the treating team.
Evidence scope and update policy